Supernus Pharmaceuticals (SUPN) Shares Outstanding (Diluted Average) (2017 - 2025)
Supernus Pharmaceuticals has reported Shares Outstanding (Diluted Average) over the past 13 years, most recently at $56.5 million for Q4 2025.
- Quarterly Shares Outstanding (Diluted Average) rose 0.88% to $56.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $56.5 million through Dec 2025, up 0.88% year-over-year, with the annual reading at $56.5 million for FY2025, 0.88% up from the prior year.
- Shares Outstanding (Diluted Average) was $56.5 million for Q4 2025 at Supernus Pharmaceuticals, up from $56.1 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $62.5 million in Q1 2023 and troughed at $54.2 million in Q1 2021.
- The 5-year median for Shares Outstanding (Diluted Average) is $55.8 million (2024), against an average of $56.6 million.
- Year-over-year, Shares Outstanding (Diluted Average) rose 13.47% in 2022 and then decreased 11.24% in 2023.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $54.4 million in 2021, then rose by 13.47% to $61.7 million in 2022, then dropped by 10.01% to $55.5 million in 2023, then increased by 0.81% to $56.0 million in 2024, then increased by 0.88% to $56.5 million in 2025.
- Per Business Quant, the three most recent readings for SUPN's Shares Outstanding (Diluted Average) are $56.5 million (Q4 2025), $56.1 million (Q3 2025), and $56.6 million (Q2 2025).